Q1 2024 Ajanta Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to the Ajanta Pharma Q1 FY2024 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you, sir.
Thank you. Good evening, and welcome, all of you. With me, I have Mr. Rajesh Agrawal, our Joint Managing Director; Mr. Arvind Agrawal, our CFO; Mr. Rajeev Agrawal, our AVP, Finance & Investor Relations.
Friends, on July 9, we celebrated a significant milestone, the 50th anniversary of Ajanta Pharma. Today, our company stands strong and distinguished within the pharmaceutical industry. We have not only stood shoulder-to-shoulder with our leading companies, but we have also carved out our own unique mark of excellence.
Over the years we have built large brands across geographies, state-of-the-art research and development center, top-notch manufacturing facilities, robust quality systems,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
